Company intelligence / Profile preview

Hoxton Farms

London, England, United Kingdom

Ownership: Private
Development stage: Preclinical

Overview

Hoxton Farms has developed a process to cultivate real animal fat from pig stem cells in bioreactors. The product serves as a drop-in ingredient for plant-based and hybrid meat alternatives. The company’s technology allows precise control over the composition of the fats produced, including nutritional profile adjustments such as lowering saturated fats or increasing omega fatty acids. They are currently scaling up operations in London and pursuing regulatory approval in markets like Japan through partnerships.

Industry: Non-Drug Biotech

Drug pipeline

1 asset

Hoxton Fat

Pre-clinical

Partnerships

Sumitomo Corporation—strategic partnership to bring cultivated pork fat to Asia-Pacific markets including Japan; working together on manufacturing integration and regulatory approval processes.

Beyond the preview

Go deeper on Hoxton Farms.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hoxton Farms.

Explore the full profile